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Live Cell Fluorescence Imaging of T Cell MEKK2:
Redistribution and Activation in Response to
Antigen Stimulation of the T Cell Receptor
transducers (Schaeffer et al., 1998; Whitmarsh et al.,
1998). Such subcellular organization may thus provide a
means by which a receptor may be coupled to a specific
MAPKKK, MAPKK, and MAPK.
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Such protein redistribution represents a consequence
of active signaling that can be visualized in fixed cellsSummary
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Redistribution in response to a specific signal providesT cell activation requires engagement of the T cell
receptor (TCR) at the interface of conjugates formed evidence that the redistributed protein plays an active
role in transducing that signal. It is therefore possiblewith antigen-presenting cells. TCR engagement is ac-
companied by a redistribution of specific signaling to use immunocytochemistry as a screening method to
determine if a given protein is likely to be involved inmolecules to the cytoplasmic region of the TCR com-
plex. In this study, immunocytochemistry and live cell the response to a signal by assessing its redistribution.
A recently developed tool for studies of this type isfluorescence imaging demonstrate that T cell MEK
kinase 2 (MEKK2) is translocated to the T cell/antigen- green fluorescent protein (GFP), which can be used as
a covalently bound tag to allow the characterization ofpresenting cell interface in response to antigen activa-
tion. MEKK2 translocation occurs more rapidly as the dynamic protein redistribution in single cells in real time.
Thus, analysis of the subcellular redistribution of MAPKantigen concentration is increased. Biochemical acti-
vation of MEKK2 follows TCR stimulation, and expres- signal transducers in response to the ligation of the
TCR should provide an accurate means of determiningsion of a dominant-negative MEKK2 inhibits TCR-
mediated conjugate stabilization and ERK and p38 whether a particular MAPK transducer is involved in the
delivery of antigen-mediated signals.MAP kinase phosphorylation. Live cell fluorescence
imaging thus enables characterization of signal trans- We have used digital fluorescence imaging of fixed
and live T cell clones to determine whether MEKKs areducers that are dynamically translocated following
TCR engagement. involved in transducing antigen-dependent signals in T
cells. We have found that endogenous T cell MEKK2,
but not MEKK1 or MEKK3, translocates to the cyto-Introduction
plasmic face of the interface with antigen-loaded pre-
senting cells. Experiments employing an MEKK2-GFPMEK kinases (MEKKs) are a family of serine-threonine
fusion protein show that translocation of MEKK2 occurskinases that have been shown to regulate mitogen-acti-
within seconds of exposure to presenting cells loadedvated protein kinase (MAPK) cascades, including the
with a highly stimulatory dose of antigen. However, asERK, p38, and JNK pathways (Fanger et al., 1997; Wid-
antigen becomes limiting, translocation of MEKK2-GFPmann et al., 1999). In MAPK cascades, the MEKKs func-
does not occur until several minutes after initial contacttion as MAPK kinase kinases (MAPKKKs) that activate
with the presenting cell. MEKK2 is activated by TCRa MAPK kinase (MAPKK), and the MAPKK then activates
stimulation, and biochemical data indicate that MEKK2a MAPK. Many MAPKKKs, including the MEKKs, are capa-
activates T cell adhesion, as well as the ERK and p38ble of activating more than one MAPK pathway. Addi-
MAPK cascades. However, MEKK2 does not appear totionally, most cell types express multiple MAPKKKs,
directly regulate IL-4 production in response to antigenwhich, in transfection/overexpression experiments, of-
stimulation. Although a complete pathway for TCR-ten appear to be functionally interchangeable (Widmann
mediated MEKK2 activation remains to be defined, ex-et al., 1999). However, emerging evidence suggests that
perimental evidence suggests that PI3-kinase may beMAPK cascades are physically compartmentalized by
an upstream modulator of MEKK2 activation. MEKK2 isscaffolding proteins that group specific MAPK signal
thus a newly identified transducer of TCR signals that
participates in the activation of specific antigen-regu-7 To whom correspondence should be addressed (e-mail: schaeferb@
njc.org). lated pathways.
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Results (94%), whereas their N-terminal domains are less related
(65% homology) (Blank et al., 1996). The observation
Translocation of T Cell MEKK2 in Response that MEKK3-YFP does not redistribute in response to
to Antigen Stimulation antigen stimulation (Figures 1C and 1D) suggests that
Because MAPK cascades are known to be involved in unique sequences in the N terminus of MEKK2 are also
multiple aspects of T cell activation (Cantrell, 1996), ex- required for translocation. Translocation in response to
periments were performed to determine if MEKK family antigen stimulation thus appears to be a very specific
members are involved in early T cell signaling. Conju- property of MEKK2, since endogenous MEKK1 and ret-
gates between T cells and antigen-pulsed presenting rovirally expressed MEKK3-YFP do not redistribute in
cells were assayed at early timepoints for MEKK protein D10 T cells.
redistribution via digital immunofluorescence micros-
copy (Monks et al., 1997, 1998). The D10 T cell clone,
The Kinetics of MEKK2 Translocation Are Dependentwhich reacts with I-Ak plus a peptide from conalbumin
upon Antigen Concentration(Kaye et al., 1983), was incubated with I-Ak-bearing
To establish how antigen concentration affects the ki-CH12.LX B cells (APC) that had been either untreated
netics of MEKK2 translocation, live cell imaging experi-or pulsed overnight with conalbumin. The T cell/APC
conjugates that formed were fixed and stained for either ments were performed on conjugates of D10/MEKK2-
MEKK1 or MEKK2 and digitally imaged. Figure 1A shows GFP T cells and APC, which had been pulsed overnight
that MEKK2 in the T cell translocated to the contact site with various concentrations of antigen. As shown in Fig-
between the T cell and APC, providing the APC had ure 2A, translocation of MEKK2-GFP occured within 10
been pulsed with antigen, whereas MEKK1 remained sec after exposure of T cells to APC that were loaded
distributed equally throughout the T cell cytoplasm. with 500 mg/ml conalbumin. At 20 mg/ml conalbumin,
To verify these data, D10 T cells were infected with a translocation was delayed, requiring approximately 40
retrovirus coding for MEKK2 fused in frame to green sec following initial APC contact. When antigen concen-
fluorescent protein (MEKK2-GFP), and a polyclonal tration was lowered to 4 mg/ml, there was a delay of
cell line was established. Detection of GFP allowed as- approximately 3 to 5 min before MEKK2-GFP transloca-
sessment of the distribution of the MEKK2-GFP fusion tion was observed. To further support the live cell im-
protein in live cells. The D10/MEKK2-GFP line was in- aging data, T cell/APC conjugates were synchronously
cubated with conalbumin-loaded APC. T cell/APC conju- initiated by brief centrifugation and were fixed 10 or 60
gates were visualized by time lapse digital microscopy. min later. Based on the data in Figure 2A, we expected
Figure 1B shows that MEKK2-GFP rapidly translocated that almost all conjugates at high antigen concentration
to the T cell APC interface and persisted for at least 30 (500 mg/ml) would also have translocated MEKK2-GFP
min (Figure 1B). As shown in Figure 1C, MEKK2-GFP but that this percentage would diminish as the antigen
did not translocate to the area of T cell/APC contact if
concentration was lowered, and that no translocations
the APC were not pulsed with the specific antigen. Simi-
would be observed in the absence of antigen. This is inlar data were obtained when primary, conalbumin-
fact what was observed (Figure 2B). Significantly, thepulsed I-Ak-bearing B cells were used (data not shown).
most substantial drop in translocation percentage oc-The amount of MEKK2-GFP protein that redistributed
cured between 4.0 and 0.8 mg/ml conalbumin, which isto the T cell/APC interface in response to antigen stimu-
the range of concentration in which antigen becomeslation was quantified (Figure 1D). Approximately 9% of
limiting for functional responses (see Figure 4A).total cellular MEKK2 is translocated to the cytoplasmic
At 60 min, the percentage of conjugates with MEKK2region of the T cell/APC contact, which represents ap-
translocations was generally less than at 10 min, sug-proximately 1.25% of the total T cell volume. Our obser-
gesting that the enrichment of MEKK2 at the T cell/APCvations indicate that the amount of MEKK2 translocated
interface may be reversed before conjugate dissocia-does not vary appreciably with antigen concentration
tion. This observation may suggest that MEKK2-GFP(data not shown). Consistent with the observations in
translocation is of shorter duration at lower antigen con-Figure 1C, no significant enrichment is observed in the
centration (Figures 2A and 2B). Although some of ourabsence of antigen. Taken together, these data demon-
live cell images seem to support the idea that MEKK2strate that the MEKK2-GFP fusion protein behaves like
translocation is transient, cell movement during imagingendogenous MEKK2 in the D10 cells and that engage-
experiments of this duration complicates their interpre-ment of the TCR on T cells causes MEKK2 within the T
cells to move rapidly and transiently to the interface tation. The data in Figures 2A and 2B do, however,
between the T cells and the APC, the site where the strongly suggest that the rate and duration of MEKK2-
TCR is capped (Kupfer and Singer, 1989). GFP translocation is directly related to the number of
Imaging experiments were also performed on a poly- specific antigen/MHC complexes present on the APC.
clonal D10 T cell line expressing a kinase-inactive form
of MEKK2, which, as shown in the experiments below,
TCR-Dependent Activation of MEKK2acts as a dominant-negative mutant (dnMEKK2-GFP).
To determine whether T cell MEKK2 is activated by TCRInterestingly, dnMEKK2-GFP does not translocate to the
engagement, the kinase activity of the MEKK2-GFP fu-T cell/APC contact site in response to antigen stimula-
sion protein in the D10/MEKK2-GFP line was testedtion (Figure 1C), indicating that an active kinase domain
using a GST-SEK1 substrate. Figure 3A shows that theis required for efficient MEKK2 translocation. To further
kinase activity of MEKK2-GFP from D10 cells that hadinvestigate the translocation phenomenon, a third poly-
been incubated with fixed, conalbumin-pulsed APC wasclonal D10 T cell line was established that expresses
43 higher than that of MEKK2-GFP isolated from D10an MEKK3 fusion protein (MEKK3-YFP). The kinase do-
mains of MEKK2 and MEKK3 are highly homologous cells incubated without APC or with fixed APC that had
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Figure 1. Translocation of T Cell MEKK2 in Response to Antigen-Loaded APC
(A) D10 T cells were mixed with APC loaded with no antigen (no ag) or with 500 mg/ml conalbumin for 10 min at 378C. Conjugates were bound
to coverslips, and MEKK2 and MEKK1 were detected by immunofluorescence microscopy using either rabbit anti-MEKK2 or rabbit anti-
MEKK1 antibodies and a Cy3-conjugated anti-rabbit secondary reagent. The upper panels are Nomarski views of the same conjugates shown
in the lower panels, which were imaged by immunofluorescence and digitally deconvolved. In each panel, the APC is the upper cell and the
D10 T cell is the lower cell.
(B) An MEKK2-GFP retrovirus was used to introduce an MEKK2-GFP fusion protein into D10 T cells. D10/MEKK2-GFP T cells were mixed
with equal numbers of conalbumin (500 mg/ml)-loaded APC, and real-time fluorescent images were acquired. Exposures of 10 sec each were
acquired at 30 sec intervals over a period of 36 min. Selected panels at the indicated timepoints are shown (APC and T cell are same orientation
as in [A]). Three similar series can be viewed as Quicktime movies at http://www.intelligent-imaging.com/njcfigs.html. Some of these additional
images show that multiple interactions result in multiple translocations, demonstrating that the observed translocations do not simply represent
reorientation of the golgi and MTOC.
(C) D10 T cells expressing MEKK2-GFP, dnMEKK2-GFP, or MEKK3-YFP were mixed for 10 min at 378C with APC that had been loaded
overnight with no antigen (no ag) or with 500 mg/ml conalbumin. Conjugates were bound to coverslips, fixed, and imaged as described in the
Experimental Procedures. Upper panels are Nomarski images, and bottom panels are digitally deconvolved fluorescence images.
(D) Conjugates prepared as described in (C) were imaged in 0.2 mm steps through the entire cell volume (10±15 mm). The data shown represent
the integral of the fluorescence intensity of the manually defined contact site over the total value of the cell. Error bars represent the standard
deviation. The manually defined contact sites represent 6.9 6 2.8% of the total cell volume. The relative enrichment of MEKK2-GFP at the
manually defined contact site is 1.03 6 0.14 when stimulated with APC that had not been pulsed with antigen (no ag) and 2.38 6 0.58 when
stimulated with APC that had been loaded with 500 mg/ml conalbumin. The relative enrichment of MEKK3-YFP at the manually defined contact
site is 1.08 6 0.11. The digitally defined contact site (calculated only for MEKK2-GFP translocation in response to antigen stimulation; see
Experimental Procedures) represents approximately 1.25% of the total cell volume and 9% of the total cellular MEKK2-GFP fluorescence.
The relative enrichment of MEKK2-GFP at the digitally defined contact is 6.75 6 1.76.
not been pulsed with antigen. As expected, no phos- T cells by antigen-pulsed APC activates MEKK2-GFP.
Furthermore, the observed activation was TCR medi-phorylation of GST-SEK1 was observed when cells that
express the kinase-inactive mutant, dnMEKK2-GFP, ated, because it was both antigen specific and accom-
plished via the use of fixed APCs, which are incapable ofwere used (data not shown). Thus, engagement of D10
Immunity
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Figure 2. Effect of Antigen Concentration on
Kinetics of MEKK2-GFP Translocation
(A) Live cell imaging is described in the Exper-
imental Procedures. APC were loaded with
the indicated concentrations of conalbumin.
In each panel, the APC is the upper (dark) cell
and the D10 T cell is the lower (bright) cell.
(B) T cell/APC conjugates were prepared,
bound to coverslips, and fixed as described
in the Experimental Procedures. Conjugates
were identified visually using Nomarski op-
tics, and fluorescence imaging was then used
to determine whether there was enrichment
of MEKK2-GFP at the T cell/APC contact site.
A total of 100±160 conjugates were examined
over two separate experiments for each con-
albumin loading concentration, and the per-
centage of conjugates that exhibited MEKK2-
GFP translocation is reported.
delivering costimulatory signals (Jenkins and Schwartz, to establish whether MEKK2 has a role in T cell MAPK
activation, we used the polyclonal D10/dnMEKK2-GFP1987; Otten and Germain, 1991; Harding et al., 1992).
line to look for evidence of inhibition of signals known
to be downstream of TCR ligation.A Dominant-Negative Form of MEKK2 Blocks TCR
Activation of the ERK and p38 MAPKs D10/MEKK2-GFP, D10/dnMEKK2-GFP, and nonin-
fected D10 cells were activated by treatment with thebut Not the JNK MAPK Pathway
Previous studies of MAP kinase activation in T lympho- stimulatory anti-TCR monoclonal antibody, 3D3 (Kaye et
al., 1983). The cells were then lysed and assayed by immu-cytes have demonstrated that cross-linking of the TCR
results in rapid activation of the ERK and p38 MAPK noblot using antibodies specific for activated, phosphory-
lated ERK-1 and ERK-2 and p38 MAPK. ERK-1 andpathways, whereas activation of the JNK MAPK path-
way requires cross-linking of both the TCR and CD28 ERK-2 were phosphorylated in D10 and D10/MEKK2-GFP
T cells in response to treatment with the anti-TCR anti-or treatment with PMA and ionomycin (Whitehurst et al.,
1992; Su et al., 1994; Cantrell, 1996; Li et al., 1996; Salmon body (Figure 3B). ERK phosphorylation was substan-
tially blocked by the MEK inhibitor, PD98059 (data notet al., 1997). Moreover, MEKK2 has been shown to be a
MAPK kinase kinase that can activate the MAPK kinases shown). In contrast, the stimulatory anti-TCR antibody
did not induce phosphorylation of ERK-1 and ERK-2 inMEK-1 and MEK-2, which are the kinases directly up-
stream of the ERK MAPKs (Fanger et al., 1997). Thus, cells expressing dnMEKK2-GFP (Figure 3B).
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Figure 3. Biochemical Analysis of Activities
of MEKK2-GFP and dnMEKK2-GFP in D10 T
Cells
(A) D10/MEKK2-GFP T cells were incubated
at 378C for 10 min alone (control) or with para-
formaldehyde-fixed APC that had previously
been untreated (APC 1 no ag) or loaded over-
night with 500 mg/ml conalbumin (APC 1 con-
alb). Immunoprecipitated MEKK2-GFP was
incubated with purified recombinant GST-
SEK1 and g-32P-ATP, and products were sep-
arated by SDS-PAGE. To measure MEKK2
kinase activity, phosphorimage analysis was
performed to quantitate phosphorylated GST-
SEK1. Relative phosphorylation units are in-
dicated beneath each lane.
(B) D10 T cells, D10/MEKK2-GFP T cells, or
D10/dnMEKK2-GFP T cells were mock treated
or incubated for 5 or 10 min at 378C with
the D10-specific, TCR-activating monoclonal
antibody 3D3. Protein extracts were pre-
pared and separated on an SDS/PAGE gel.
Phosphorylated ERK-1 (phos ERK-1) and
phosphorylated ERK-2 (phos ERK-2) were de-
tected with an anti-phospho-ERK-1/-2 anti-
body (upper panel). This blot was then stripped
and blotted with anti-ERK-1 and anti-ERK-2 an-
tibodies, as shown in the lower panel.
(C) D10 T cells, D10/MEKK2-GFP T cells, or D10/dnMEKK2-GFP T cells were mock treated or incubated for 5 or 10 min at 378C with the
D10-specific, TCR-activating monoclonal antibody 3D3. Protein extracts were prepared and separated on SDS-PAGE gels as described in
(B). Phosphorylated p38 MAPK (phos p38) was detected with an anti-phospho-p38 MAPK antibody (upper panel). The same blot was stripped
and blotted with an anti-p38 antiserum, as shown in the lower panel.
(D) D10 T cells or D10/dnMEKK2-GFP T cells were mock treated (control) or activated for 5 min at 378C by the addition of PMA and Ionomycin
(PMA 1 iono). Cells were disrupted and cJun NH2-terminal kinase (JNK) activity was assayed using a GST-c-Jun kinase assay. Reaction
products were separated by SDS-PAGE, and 32P-labeled GST-cJun was quantified using a phosphorimager. Relative phosphorylation units
are indicated beneath each lane.
Stimulation of D10 or D10/MEKK2-GFP cells with the one or more cell surface proteins required for efficient
interaction with APCs, FACS analyses were used toanti-TCR 3D3 antibody also rapidly induced p38 phos-
phorylation (Figure 3C). Expression of dnMEKK2-GFP measure surface expression of molecules that contrib-
ute to conjugate formation. All but one of the proteinsinhibited this phenomenon. This result was somewhat
surprising because transfection analyses in other cell monitored (TCRb, CD4, CD28, LFA-1, ICAM-1, and CD2)
varied less than 2-fold in their levels on the three D10types have not demonstrated p38 activation in response
to transient overexpression of full-length MEKK2 or its cell lines (data not shown). The one notable exception
was CD28, which, in comparison to D10 T cells, waskinase domain (Fanger et al., 1997; Widmann et al., 1999).
In contrast to the ERK and p38 MAPK pathways, PMA/ substantially decreased on the D10/MEKK2-GFP line
and modestly increased on the D10/dnMEKK2-GFP line.ionomycin-mediated activation of JNK was not signifi-
cantly inhibited by expression of dnMEKK2-GFP (Figure Because CD28 probably contributes to regulation of T
cell/B cell interactions, this CD28 phenotype did not3D). Therefore, dnMEKK2-GFP selectively inhibits the
ERK and p38 MAP kinase pathways that are activated correlate with the observed decrease in specific conju-
gate formation of the D10/dnMEKK2-GFP T cells.by engagement of the TCR alone but does not inhibit the
JNK pathway, which also requires costimulatory signals. The fact that expression of dnMEKK2-GFP reduced
the ability of T cells to respond to antigen and to formActivation of MEKK2 is thus downstream of TCR ligation
and is not dependent upon the cross-linking of addi- conjugates suggested that dnMEKK2-GFP affected a
feature of T cell activation that contributes to both oftional cell surface molecules.
these activities. Previous studies of T cell activation
have shown that antibodies to T cell adhesion proteins,MEKK2 Influences T Cell Adhesion
such as the integrin LFA-1, have effects similar to thoseTo assay the effects of dnMEKK2-GFP on T cell function,
shown here with dnMEKK2-GFP expression (DavignonD10 and its MEKK2-GFP infectants were tested for their
et al., 1981; Golde et al., 1986). Engagement of TCRsability to secrete IL-4 in response to antigen and APC.
on T cells leads to a rapid and transient increase in theFigure 4A demonstrates that expression of dnMEKK2-
avidity of T cell LFA-1 for its ligands on other cells (DustinGFP reduced the sensitivity of D10 cells to low concen-
and Springer, 1989). In turn, this increase in avidity con-trations of antigen. In time-lapse microscopy studies,
tributes to the ability of activated T cells to bind to targetwe observed that expression of dnMEKK2-GFP by D10
cells and produce cytokines. Anti-LFA-1 has a modestboth slowed the formation and reduced the number of
effect on the ability of T cells to secrete cytokines inconjugates that D10 formed with antigen-pulsed APC
response to antigen and a more dramatic effect on their(data not shown). To address the possibility that D10/
dnMEKK2-GFP T cells might have reduced levels of ability to form conjugates with antigen-pulsed APCs
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Figure 4. Effect of Expression of MEKK2-
GFP and dnMEKK2 GFP on Antigen-Depen-
dent T Cell Responses
(A) The indicated D10 T cells were mixed with
APC that had been loaded overnight with the
indicated concentrations of conalbumin pro-
tein. Supernatants were harvested following
6 hr incubation at 378C. IL-4 concentrations
were measured by capture ELISA and cali-
brated to a recombinant IL-4 standard curve.
Error bars represent SEM, and the majority
are contained within the symbols.
(B) APC were labeled with the red dye PKH-
26 and then loaded with the indicated con-
centration of conalbumin protein or with no
antigen. The D10 and D10/dnMEKK2-GFP T
cell lines were labeled with the green dye
CFSE. Each D10 T cell line was then incu-
bated for at least 30 min at 378C with no anti-
body, or 100 mg/ml of blocking antibodies
directed against LFA-1 or CD4. For each sam-
ple, T cells were mixed with an equal number
of APC and incubated for exactly 16 min at
378C. Nonspecific aggregates were disrupted
by vortexing, and samples were analyzed by
flow cytometry. A representative set of two-
dimensional plots of D10/MEKK2-GFP T cells
(green) versus PKH-26-labeled APC (red) is
shown. In this example, T cells were preincu-
bated with no antibody or anti-LFA-1 anti-
body, and APC were loaded with conalbumin
(20 mg/ml) or no antigen. The number in each
plot is percent conjugates.
(C and D) Tabulation of data collected from
flow cytometry experiments described in (B).
In each graph, percent (%) conjugates versus
concentration of conalbumin used for APC
loading is shown. In (C), each untreated cell
line (no antibody) is shown on a single graph.
In (D), each cell line is shown on a separate
graph, with all three treatment groups (no an-
tibody, anti-LFA-1, and anti-CD4) shown. Er-
ror bars represent SEM, and the majority are
contained within the symbols.
(Davignon et al., 1981; Golde et al., 1986; Dustin and dnMEKK2-GFP infectants to form conjugates with anti-
gen-pulsed APC in the absence or presence of anti-Springer, 1989). Interestingly, there is at least one report
that the ERK MAPK pathway contributes to TCR regula- LFA-1 antibodies. Wild-type D10 cells were labeled with
the green fluorescent dye CFSE (Molecular Probes), andtion of integrin avidity (Mobley et al., 1996).
Several additional findings suggest a relationship be- the APC were labeled with the red fluorescent dye PKH-
26 (Sigma). T cells and B cells were mixed in equaltween the effects of dnMEKK2-GFP and activation of
LFA-1. For example, both antigen-stimulated MEKK2- numbers and incubated for 16 min. Conjugates were
counted by measuring the numbers of cell aggregatesGFP translocation and increases in LFA-1 adhesion to
its ligand, ICAM-1, occur with rapid kinetics and have that fluoresced both green and red. As shown in Figure
4B, many such conjugates were formed when D10/a duration of at least 30 min (Figures 1A, 1B, and 2A;
data not shown; Dustin and Springer, 1989). Additionally, MEKK2-GFP cells were incubated with conalbumin-
pulsed APC. Formation of these conjugates was almostboth biochemical activation of MEKK2-GFP and upregu-
lation of LFA-1 avidity occur rapidly in response to treat- entirely dependent on the presence of antigen, since
very few conjugates appeared in mixtures of D10/ment with either PMA or anti-T cell receptor antibodies.
Finally, after a primary TCR-mediated stimulation, both MEKK2-GFP cells and APC that had not been pulsed
with antigen. Conjugate formation was also dependentMEKK2-GFP translocation and LFA-1 avidity upregula-
tion can recur if an activation signal is delivered a second to a large extent on LFA-1 activity, since anti-LFA-1
antibody reduced the numbers of conjugates substan-time (data not shown; Dustin and Springer, 1989). Thus,
MEKK2 is likely to be involved in delivering the TCR- tially, from 21.7% to 3.5% of the cells (Figure 4B).
When these methods were applied in an antigen titrationmediated signals that directly or indirectly result in in-
creased avidity of T cell LFA-1 for its ligand on APCs. experiment, it was clear that dnMEKK2-GFP affected TCR
regulation of adhesion. Wild-type D10 cells and D10/To test this hypothesis, we measured the ability of
wild-type D10 cells and their MEKK2-GFP or their MEKK2-GFP T cells formed substantial numbers of con-
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jugates at all antigen doses tested, whereas cells ex-
pressing dnMEKK2-GFP formed significantly fewer con-
jugates when incubated with antigen-pulsed APC, par-
ticularly as the antigen concentration was decreased
(Figure 4C). Significantly, at all but the lowest dose of
antigen, expression of MEKK2-GFP increased the num-
ber of conjugates formed, demonstrating that overex-
pression of enzymatically active MEKK2 enhances con-
jugate formation.
To investigate the mechanism of dnMEKK2-GFP inhi-
bition of adhesion, conjugate assays were performed
on the D10 cell lines following preincubation with anti-
LFA-1 or anti-CD4 blocking antibodies. In general, D10,
D10/MEKK2-GFP, and D10/dnMEKK2-GFP formed sub-
stantially fewer conjugates when preincubated with ei-
ther antibody (Figure 4D). These observations demon-
strate that although conjugate formation is strongly
inhibited by dnMEKK2-GFP, there is not a complete
block in either LFA-1-mediated adhesion or in CD4-
mediated signaling events that participate in antigen-
regulated adhesion.
PI3-Kinase Is a Probable Upstream Mediator
of TCR Activation of MEKK2
Previous studies have shown that phosphatidylinositol
3-kinase (PI3-K) is involved in antigen-regulated T cell
adhesion. Evidence from several groups indicates that
PI3-K can increase LFA-1 avidity by activating cytoskel-
etal modifying proteins that facilitate cell spreading and
membrane ruffling (Pardi et al., 1992; Shimizu and Hunt,
1996; Stewart and Hogg, 1996; Shi et al., 1997; Han et
al., 1998). To determine whether PI3-K may be upstream
of the MEKK2-driven regulation of T cell avidity, we
studied the effects of the PI3-K inhibitor wortmannin on
the binding of D10 and its derivatives to antigen-pulsed
APC (Figure 5A). Consistent with the findings in Figure
4C, D10/dnMEKK2-GFP cells made fewer conjugates
than either D10 or D10/MEKK2-GFP T cells. Wortmannin
inhibited conjugate formation by all three cell types,
and the amount of inhibition was comparable to that
observed with the anti-LFA-1 antibody, consistent with
the model that PI3-K is upstream of LFA-1. Addition-
Figure 5. Effect of the PI3-Kinase Inhibitor Wortmannin on T Cell/
ally, the binding of anti-TCR-stimulated D10 T cells to APC Conjugates and MAPK Activation
ICAM-1 expressing fibroblasts was inhibited almost com- (A) The indicated T cell lines were mock treated (control) or preincu-
pletely by wortmannin, demonstrating that TCR activa- bated for 30 min with 100 nM wortmannin or with 100 mg/ml of
tion of LFA-1-mediated adhesion requires PI3-K activity the anti-LFA-1 antibody I21/7.7. APC were loaded with 500 mg/ml
conalbumin or no antigen, and conjugate assays were as described(data not shown). A combination of wortmannin and anti-
in Figures 3B and 3C. Values are plotted as percent (%) specificLFA-1 did not inhibit conjugate formation by D10 cells
conjugates. Error bars represent SEM. Similar results were obtainedmuch more potently than either agent alone, demonstrat-
with another PI3-K inhibitor, LY294002 (data not shown).
ing that the majority of the effect of PI3-K on conjugate (B) D10 T cells were mock treated or incubated for 30 min with 100
formation is via LFA-1 (data not shown). Finally, the nM wortmannin, as indicated. T cells were then incubated with me-
observation that inhibition of conjugate formation by dia for 10 min (control) or activated with supernatant from TCR-
activating antibody (3D3) for the indicated time periods. WesterndnMEKK2-GFP dramatically reduces the ability of wort-
blots for phosphorylated and total ERK and p38 MAPKs were per-mannin to block adhesion (Figure 5A) suggests that
formed and are labeled as in Figures 2B and 2C.MEKK2 and PI3-K may be in a common pathway that
connects the TCR to a cellular function that contributes
to LFA-1 avidity.
p38 is also inhibited by wortmannin in D10 cells, indicat-In other studies, we have found that wortmannin inhib-
ing that MEKK2 regulation of ERK and p38 is down-its MEKK2 activation in response to EGF or high-affinity
stream of PI3-K. Thus, several lines of evidence indicateIgE receptor ligation in T47D breast carcinoma and mast
that MEKK2 is a PI3-kinase-dependent transducer ofcells, respectively, demonstrating that MEKK2 activa-
TCR signals that activate T cell adhesion and the ERKtion is dependent upon PI3-K (G. J. et al., unpublished
data). Figure 5B shows that TCR activation of ERK and and p38 MAPK cascades.
Immunity
418
Discussion conformational changes, the mechanism(s) by which
MEKK2 contributes to increased LFA-1 avidity may be
We have used live-cell imaging to provide real-time anal- quite indirect. The discovery that MEKK2 is recruited to
ysis of the intracellular redistribution of a signaling pro- the T cell/APC interface and regulates adhesion will
tein in response to antigen stimulation of the T cell re- allow a genetic and biochemical dissection of this TCR-
ceptor. This study also provides evidence that MEKK2 regulated response, a response that has been largely
is activated and is required for activation of the ERK refractory to analysis up to this time.
and p38 MAPK pathways in response to TCR ligation. The finding that MEKK2 translocation can occur
Although other MAPKKKs, particularly Raf-1, have pre- within seconds (Figures 1B and 2A) indicates that this
viously been suggested to activate the ERK pathway in relocalization is one of the earliest known TCR-depen-
response to TCR stimulation (Siegel et al., 1990; Owaki dent activation events (Chan et al., 1991). Interestingly,
et al., 1993; Siegel et al., 1993; Franklin et al., 1994; Gupta MEKK2-GFP translocation is delayed at low antigen
et al., 1994; Izquierdo et al., 1994), a study employing concentration (Figures 2A and 2B), while the net per-
primary murine T cells has also shown that ligation of centage of total cellular MEKK2-GFP translocated to
additional receptors, including CD2, CD4, and CD28, is the contact site appears to be independent of antigen
also capable of activating Raf-1 (Siegel et al., 1993). concentration (Figures 1D and 2A; data not shown).
However, ligation of CD28 does not result in p38 phos- These observations may suggest that MEKK2 transloca-
phorylation (Salmon et al., 1997). Our findings would tion reaches maximal levels only after a signaling thresh-
suggest that Raf-1 is more likely to play an accessory old has been reached or an active signaling complex
or costimulatory role in T cell activation, whereas MEKK2 has formed. MEKK2-GFP translocation may thus be a
is a MAPKKK that directs antigen-regulated responses. visual proxy of TCR triggering, which occurs within sec-
We have demonstrated that antigen ligation of the onds after the TCR has been functionally engaged. A
TCR activates MEKK2 and that dnMEKK2-GFP inhibits potentially important application of our current findings
aspects of TCR signaling. Importantly, the effect of would be to use recombinant MHC complexes of spe-
dnMEKK2-GFP in D10 T cells is selective for specific cific valency and geometry to define agonists that are
aspects of TCR signaling. Activation of the ERK and p38 capable of effecting TCR-mediated MEKK2-GFP trans-
pathways are blocked by dnMEKK2-GFP expression, location. Such studies may provide important informa-
but activation of JNK is not perturbed (Figures 3B±3D). tion regarding the nature of the activated TCR signaling
Conjugate stability is inhibited, but D10/dnMEKK2-GFP complex (Germain, 1997) and facilitate resolution of the
cells make an amount of IL-4 essentially indistinguish- debate concerning the minimal requirements for initia-
able from the D10 and D10/MEKK2-GFP cell lines when tion of the TCR signaling cascade (Boniface et al., 1998;
activated by APC loaded with high concentrations of Delon et al., 1998; Vignali and Vignali, 1999).
antigen (see Figure 4A). Because the production of IL-4 Live cell fluorescence imaging proved to be a powerful
in response to TCR stimulation is a complex biological diagnostic tool for defining subcellular relocalization and
response that involves the integration of numerous potential functions of signaling proteins during a complex
signaling pathways, it seems extremely unlikely that biological response. This method should facilitate the
dnMEKK2-GFP has nonspecifically perturbed signal characterization of other crucial signaling proteins that
transduction pathways. The ERK MAPK pathway has redistribute in response to receptor ligation or other
been shown to have little influence on IL-4 production biochemical stimuli. Beyond confirming results obtained
(Dumont et al., 1998), consistent with our results. Addi- by immunocytochemistry, live cell fluorescence imaging
tionally, we would emphasize that the kinetics of the allows investigation of the dynamics of protein redistri-
signal transduction events inhibited by dnMEKK2-GFP bution and reorganization in single cells in real time.
(Figures 3B and 3C) are consistent with the kinetics Because this technology makes possible the visualiza-
of translocation of endogenous MEKK2 and transloca-
tion and dissection of rapidly occurring, complex redis-
tion and activation of MEKK2-GFP (Figures 1A, 1B, 2A,
tribution events, live cell fluorescence imaging is a tech-
and 3A).
nique that makes possible the study of the temporalAlthough it is reasonable to postulate that the effects
component of subcellular protein reorganization.of MEKK2 on T cell adhesion might be mediated by the
ERK or p38 MAPK pathways, our analyses with the MEK
inhibitor PD98059 and the p38 inhibitor SB203580 have Experimental Procedures
shown no significant effect of these compounds on con-
Antibodiesjugate formation (data not shown). Thus MEKK2, like
The polyclonal rabbit anti-MEKK1 and anti-MEKK2 antibodies usedother MAPKKKs, including MEKK1 and PAK, appears
in fluorescence microscopy experiments have been previously de-
capable of activating non-MAPK signaling pathways scribed (Fanger et al., 1997), and the Cy3-conjugated anti-rabbit
(Widmann et al., 1999). secondary antibody was purchased from Jackson Laboratories. For
As shown in Figure 5A, MEKK2 is a required signal some T cell/APC conjugate analyses, blocking antibodies directed
transducer for a PI3-K-regulated adhesion pathway that against LFA-1 (I21/7.7) or CD4 (GK1.5) (Trowbridge and Omary, 1981;
Dialynas et al., 1983) were used. These were prepared from hybrid-contributes to increased LFA-1 avidity. Because the
oma supernatants by purification over protein G agarose columns.MEKK2 protein does not include a pleckstrin-homology
In ELISA experments, the monoclonal antibody BVD4-1D11 (Phar-domain, we postulate that TCR-mediated MEKK2 acti-
Mingen) was used for IL-4 capture and the biotinylated monoclonal
vation is downstream of one or more proteins that are antibody BVD6-24G2 (PharMingen) was used for IL-4 detection.
directly acted upon by products of PI3-K. Given that For Western blotting experiments, T cells were activated by incu-
LFA-1 avidity can be affected by diverse processes bation with the anti-D10 TCR monoclonal antibody 3D3, which does
not require addition of cross-linking secondary antibody (Kaye etincluding cell spreading, LFA-1 clustering, and LFA-1
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al., 1983). Phosphorylated ERK-1 and phosphorylated ERK-2 were contact site was defined either manually or digitally. Digital definition
was available only for the antigen-stimulated D10/MEKK2-GFP celldetected with a rabbit polyclonal anti-phospho-MAPK antibody
(New England Biolabs), and phosphorylated p38 MAPK was de- line, since MEKK2-GFP localizes to the contact interface and gener-
ates a contact site identifiable by fluorescence. Therefore, sincetected with a rabbit polyclonal anti-phospho-p38 MAPK antibody
(New England Biolabs). Total ERK-1 and ERK-2 were detected using translocation was not a feature of all cell lines and conditions under
comparison, manual definition was used. Manual definition resultspolyclonal goat anti-ERK-1 and rabbit anti-ERK-2 antibodies (Santa
Cruz Biotechnology). Total p38 was detected using a rabbit poly- in a much larger contact volume, resulting in an artificially inflated
localization percentage for MEKK2. We therefore reported both theclonal anti-p38 antiserum.
manual and digital values for percent localization. We have also
reported the relative enrichment (see the legend to Figure 1D), whichCells and Retroviral Infection
is the fluorescence per unit volume at the contact site divided byThe T cell clone D10 (Kaye et al., 1983) and all described D10-
the fluorescence per unit volume of the entire cell.derived lines were maintained in Click's (EHAA) media (Irvine Scien-
tific) supplemented with 10% fetal bovine serum and 8 U/ml IL-2.
IL-4 ELISACells were transferred to media lacking IL-2 approximately 20 hr
The indicated D10 T cell lines (106/ml) were mixed with an equalbefore use in experiments. The CH12.LX B cell line (APC) was main-
volume of APC (106/ml) that had been loaded overnight with thetained in minimal essential media (MEM) (Gibco/BRL) supplemented
indicated concentrations of conalbumin protein. Supernatants wereas described (Kappler et al., 1981). Murine cDNA clones encoding
harvested and frozen following 6 hr incubation at 378C. IL-4 concen-either MEKK2 or a F502L kinase inactive mutant (dnMEKK2) were
trations were measured by capture ELISA, using recombinant mu-modified by the truncation of the 59 untranslated region and intro-
rine IL-4 (R&D Systems) to generate a standard curve. The mono-duction of an NcoI restriction site at the initial methionine (CCATGG).
clonal antibody BVD4-1D11 was bound to the wells of a 96-wellThe MEKK2 stop codon was also removed and replaced with a
ELISA plate, IL-4 was captured from 200 ml of each supernatant bysynthetic linker, adding the residues Gly Arg. These modified MEKK2
incubation at ambient temperature for 1 hr, and IL-4 was detectedcDNAs were then fused to the N terminus of an open reading frame
using the biotinylated monoclonal antibody BVD6-24G2. Followingencoding the red-shifted, humanized green fluorescent protein vari-
incubation with extravidin alkaline phosphatase and hydrolysis ofant EGFP (Clontech), altered by deletion of the first GFP codon and
the substrate p-nitrophenyl phosphate, ELISA samples were readintroduction of the ªcycle 3º mutations described by Crameri et al.
at 405 nm on a microplate reader (BioTek).(1996). MEKK2-GFP fusion genes were cloned upstream of an inter-
nal ribosome entry site (IRES)-neomycin resistance (NeoR) cassette,
and the MEKK2-GFP/IRES-NeoR inserts were cloned into the NcoI Conjugate Assays
and BamHI sites of the MFG retroviral vector (Riviere et al., 1995). APC were labeled with the dye PKH-26 (Sigma) according to the
The MEKK3-YFP retrovirus was created by identical methodology. instructions of the manufacturer and then loaded for 16 hr with 500,
YFP is a previously described spectral variant of GFP (Ormo et al., 100, 20, or 4 mg/ml conalbumin protein or with no antigen. The D10
1996). The MEKK3-YFP fusion was cloned upstream of an IRES- and D10/dnMEKK2-GFP T cell lines were labeled with 0.1 and 0.025
hygromycin (HygR) resistance cassette in the MFG vector. Retroviral mM, respectively, CFSE (Molecular Probes) for 15 min at 378C in 13
plasmid constructions were transfected into the packaging line BSS, approximately 16 hr prior to initiation of the experiment. Each
Phoenix-Eco (Kinsella and Nolan, 1996). The D10 T cell line was D10 T cell line was then incubated for at least 30 min at 378C with
infected by coculture with the packaging line, followed by G418 or no antibody or 100 mg/ml of blocking antibodies directed against
hygromycin selection. The resulting G418R or HygR cultures were LFA-1 (I21/7.7) or CD4 (GK1.5) (Trowbridge and Omary, 1981; Dialy-
sorted for high GFP or YFP fluorescence by the National Jewish nas et al., 1983). For each sample, 20 ml of T cells (107/ml) was
Flow Cytometry Core Facility. mixed in a 1.5 ml microcentrifuge tube with an equal volume of
In certain T cell/APC conjugate assays and Western blotting ex- APC (107/ml) and incubated for exactly 16 min at 378C. Nonspecific
periments, T cells were preincubated for 30 min with 100 nM wort- aggregates were disrupted by vortexing, and samples were ana-
mannin. This dose of wortmannin over the 30 min preincubation lyzed using a FACScan flow cytometer (Beckton-Dickinson). For
plus 16 min conjugate formation period (or 10 min 3D3 antibody each sample, 4 3 104 live-gated events (i.e., live cells or live cell
treatment period) was judged to be nontoxic because flow cytome- conjugates) were collected and analyzed. Two-dimensional plots of
try analysis of the conjugate assay samples did not demonstrate a T cells (FL1 channel, GFP and/or CFSE fluorescence) versus APC
significantly higher percentage of dead cells in the wortmannin- (FL2 channel, PKH-26 fluorescence) were generated. Percent conju-
treated samples versus untreated or antibody-treated samples. gates, defined as the number of live-gated, double-positive events
in the upper right quadrant divided by the total number of live-gated
events, was then determined for each sample. In Figure 5A, valuesImmunocytochemistry and Cell Imaging Analysis
are expressed as percent specific conjugates, which is definedConjugates were formed by mixing a 1:1 or 1:2 ratio of T cells to
as percent conjugates in the APC/no antigen samples subtractedAPC. For fixed cell experiments, mixing was followed immediately
from the percent conjugates calculated for each APC/conalbuminby centrifugation in a Stratagene PicoFuge for 20 sec, and cell
sample.mixtures were placed in a CO2 incubator at 378C for the indicated
time periods. For immunocytochemistry experiments, T cell/APC
conjugates were bound to washed, poly-D-lysine-coated coverslips MEKK2 and JNK Assays
To assay kinase activity of MEKK2-GFP, D10/MEKK2-GFP T cells(3 mg/ml), fixed for 10 min with 3% paraformaldehyde/3% sucrose,
and stripped of membranes by 5 min treatment with 0.2% Triton (2 3 107) were incubated at 378C for 10 min alone or with the indi-
cated paraformaldehyde-fixed APC (2 3 107). Cells were disruptedX-100 in 13 PBS. Conjugates were stained with indicated antibodies
and were observed using a Leica DMXRA epifluorescence micro- in lysis buffer (20 mM Tris [pH 7.6], 0.5% NP-40, 250 mM NaCl, 3
mM EDTA, and 3 mM EGTA), nuclei were pelleted by centrifugationscope. Visual data were acquired using a Cooke Corporation Sensi-
Cam CCD camera and were digitally deconvolved using a nearest at 12,000 3g for 10 min at 48C, and MEKK2-GFP was immunoprecipi-
tated using a polyclonal rabbit anti-GFP antibody (Clontech) andneighbors algorithm with SlideBook software (Intelligent Imaging
Corporation). In live-cell imaging experiments, T cells and APC (each protein A sepharose. Immunoprecipitates were washed twice with
lysis buffer and once with kinase buffer (20 mM HEPES [pH 7.5], 20at approximately 2 3 105/ml) were mixed in medium buffered with
25 mM HEPES (pH 7.4), and real-time fluorescent images were gath- mM b-glycerophosphate, 10 mM p-nitrophenyl phosphate, 10 mM
MgCl2, 10 mM MnCl2, 1 mM DTT, and 50 mM Na3VO4). A MEKK2ered with a 403 water immersion objective and a Bioptechs stage
heater set to 378C. Short exposure times and a xenon light source kinase assay was performed by incubating the immunoprecipitate
with bacterially produced recombinant GST-SEK1 and g-32P-ATP atwere used to minimize bleaching effects.
Conjugate contact analysis was performed using the masking and 308C for 20 min in kinase buffer. Phosphorylation of GST-SEK1 was
determined by boiling the products of the kinase reaction in 13statistics capabilities of SlideBook. Initially, stacks of images were
acquired in 0.2 mm steps throughout the contact volume. Stacks Laemmli buffer, followed by SDS-PAGE electrophoresis and quanti-
tation of 32P-labeled GST-SEK1 using a phosphorimager.were deconvolved using a nearest neighbors algorithm, and the
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For the cJun NH2-terminal kinase (JNK) assay, D10 T cells or D10/ monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-
3/T4 molecule. J. Immunol. 131, 2445±2451.dnMEKK2-GFP T cells (107) were mock treated or activated for 5
min at 378C by the addition of 10 ng/ml PMA (Sigma) and 1 mM Dumont, F.J., Staruch, M.J., Fischer, P., DaSilva, C., and Camacho,
Ionomycin (Calbiochem). Cells were disrupted in lysis buffer, JNK R. (1998). Inhibition of T cell activation by pharmacologic disruption
was precipitated from lysates using GST-cJun-sepharose beads, of the MEK1/ERK MAP kinase or calcineurin signaling pathways
and a GST-c-Jun kinase assay was performed as previously de- results in differential modulation of cytokine production. J. Immunol.
scribed (Fanger et al., 1997). Reaction products were separated on 160, 2579±2589.
a 10% SDS-PAGE gel, and 32P-labeled GST-cJun was quantified Dustin, M.L., and Springer, T.A. (1989). T-cell receptor cross-linking
using a phosphorimager. transiently stimulates adhesiveness through LFA-1. Nature 341,
619±624.
Western Blotting Fanger, G.R., Johnson, N.L., and Johnson, G.L. (1997). MEK kinases
D10 T cells or D10/dnMEKK2-GFP T cells (107) were pretreated as are regulated by EGF and selectively interact with Rac/Cdc42.
indicated in the figure legends and were then incubated for the EMBO J. 16, 4961±7492.
indicated times at 378C without stimulation or with the D10-specific
Franklin, R.A., Tordai, A., Patel, H., Gardner, A.M., Johnson, G.L.,TCR-activating monoclonal antibody 3D3 (10 mg/ml of Protein
and Gelfand, E.W. (1994). Ligation of the T cell receptor complexG±purified antibody). Protein extracts were prepared by disrupting
results in activation of the Ras/Raf-1/MEK/MAPK cascade in humancells in lysis buffer followed by pelleting of the nuclei by centrifuga-
T lymphocytes. J. Clin. Invest. 93, 2134±2140.tion at 12,000 3g for 10 min at 48C. Proteins were denatured by
Germain, R.N. (1997). T-cell signaling: the importance of receptorboiling in Laemmli buffer, and 2.5 3 106 cell equivalents per sample
clustering. Curr. Biol. 7, R640±R644.were separated on a 10% SDS/PAGE gel. Proteins were transferred
to nitrocellulose and detected using the indicated anti-phospho- Golde, W.T., Gay, D., Kappler, J., and Marrack, P. (1986). The role
MAP kinase antibody and a standard chemiluminescence protocol. of LFA-1 in class II restricted, antigen-specific T-cell responses.
Where indicated, blots were stripped and reblotted. Cell. Immunol. 103, 73±83.
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